Alps Advisors Inc Adaptimmune Therapeutics PLC Transaction History

Alps Advisors Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.06 - $2.41 $8,237 - $18,728	-7,771 Reduced 8.09%	88,339 $95,000
Q2 2022 Aug 11, 2022	BUY	$1.33 - $2.28 $127,826 - $219,130	96,110 New	96,110 $163,000
Q4 2021 Feb 09, 2022	SELL	$3.5 - $5.68 $666,925 - $1.08 Million	-190,550 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.44 - $6.37 $48,934 - $90,613	-14,225 Reduced 6.95%	190,550 $985,000
Q2 2021 Aug 11, 2021	SELL	$3.86 - $5.78 $289,654 - $433,731	-75,040 Reduced 26.82%	204,775 $872,000
Q1 2021 May 07, 2021	BUY	$4.9 - $6.83 $1,298 - $1,809	265 Added 0.09%	279,815 $1.49 Million
Q4 2020 Feb 03, 2021	BUY	$4.0 - $9.2 $329,520 - $757,895	82,380 Added 41.78%	279,550 $1.51 Million
Q3 2020 Nov 04, 2020	SELL	$7.66 - $10.78 $63,409 - $89,236	-8,278 Reduced 4.03%	197,170 $1.57 Million
Q2 2020 Aug 05, 2020	BUY	$2.58 - $12.1 $262,210 - $1.23 Million	101,632 Added 97.9%	205,448 $2.06 Million
Q2 2018 Jul 25, 2018	SELL	$10.42 - $13.74 $227,562 - $300,067	-21,839 Reduced 17.38%	103,816 $693,000
Q1 2018 May 01, 2018	BUY	$7.1 - $11.56 $155,056 - $252,458	21,839 Added 21.04%	125,655 $1.41 Million
Q4 2017 Feb 05, 2018	BUY	$6.68 - $8.74 $78,262 - $102,397	11,716 Added 12.72%	103,816 $693,000
Q3 2017 Nov 03, 2017	BUY	$4.93 - $8.93 $454,053 - $822,453	92,100	92,100 $754,000

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $96.4M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.